...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Blood pressure variability in risk stratification: What does it add?
【24h】

Blood pressure variability in risk stratification: What does it add?

机译：风险分层中的血压变异性：它增加了什么？

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Summary: In this minireview we address the predictive value of blood pressure variability, over and beyond level of pressure, in randomly selected population samples. All reviewed studies had sufficient power, long follow-up duration and a wide age range. We assessed blood pressure variability derived from home visit, self-measured home pressure and 24 h ambulatory monitoring. The conclusions are based mainly on novel indices of blood pressure variability: variability independent of the mean, difference between maximum and minimum blood pressure and average real variability. None of these variability indices or morning surge in blood pressure substantially refined risk profiling over and beyond the blood pressure level. In risk stratification, clinicians should concentrate on blood pressure level, the predominant risk factor modifiable by lifestyle measures and antihypertensive drug treatment. Clinical and Experimental Pharmacology and Physiology
机译：简介：在本小型回顾中，我们探讨了随机选择的人群样本中血压变异性在压力水平之上和之外的预测价值。所有经过审查的研究均具有足够的能力，较长的随访时间和较宽的年龄范围。我们评估了从家庭访视，自我测量的家庭压力和24小时动态监测得出的血压变异性。结论主要基于新的血压可变性指标：可变性独立于均值，最大和最小血压之间的差异以及平均实际可变性。这些可变性指数或早晨血压的升高均无法完全改善超出或超出血压水平的风险状况。在风险分层中，临床医生应专注于血压水平，这是可通过生活方式措施和降压药物治疗改变的主要危险因素。临床和实验药理和生理学

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号